PharmAbcine Inc.
Clinical-stage biotech developing human monoclonal antibodies for various diseases.
208340 | KO
Overview
Corporate Details
- ISIN(s):
- KR7208340000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
- Website:
- http://pharmabcine.com/
- Sector:
- Manufacturing
Description
PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-12-18 00:00 |
경영권변경등에관한계약체결
|
Korean | 14.6 KB | ||
| 2023-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2023-12-13 00:00 |
[기재정정]분기보고서 (2023.09)
|
Korean | 1.7 MB | ||
| 2023-12-08 00:00 |
임시주주총회결과
|
Korean | 9.0 KB | ||
| 2023-12-05 00:00 |
투자판단관련주요경영사항([국책과제 선정]first in class tie2 activator PMC-403의 연령관련 황반변성 환자대상 임상 …
|
Korean | 8.2 KB | ||
| 2023-12-01 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 22.0 KB | ||
| 2023-12-01 00:00 |
기타주요경영사항(제3자배정 유상증자 철회)
|
Korean | 4.8 KB | ||
| 2023-11-30 00:00 |
투자판단관련주요경영사항(경영지배인 해임의 건)
|
Korean | 5.5 KB | ||
| 2023-11-27 00:00 |
[기재정정]주주총회소집결의(임시주주총회)
|
Korean | 25.7 KB | ||
| 2023-11-23 00:00 |
[기재정정]주주총회소집결의(임시주주총회)
|
Korean | 27.9 KB | ||
| 2023-11-23 00:00 |
주주총회소집공고
|
Korean | 70.2 KB | ||
| 2023-11-23 00:00 |
의결권대리행사권유참고서류
|
Korean | 59.4 KB | ||
| 2023-11-17 00:00 |
최대주주변경
|
Korean | 13.9 KB | ||
| 2023-11-16 00:00 |
[기재정정]분기보고서 (2023.09)
|
Korean | 1.4 MB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmAbcine Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
